Natco Pharma (BOM:524816) 3-Year Book Growth Rate : 13.10% (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma 3-Year Book Growth Rate?

Natco Pharma's Book Value per Share for the quarter that ended in Mar. 2024 was ₹326.79.

During the past 12 months, Natco Pharma's average Book Value per Share Growth Rate was 22.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was 13.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was 10.50% per year. During the past 10 years, the average Book Value per Share Growth Rate was 22.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Natco Pharma was 48.50% per year. The lowest was 7.00% per year. And the median was 18.70% per year.

Competitive Comparison of Natco Pharma's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natco Pharma's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Natco Pharma's 3-Year Book Growth Rate falls into.

Natco Pharma 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Natco Pharma (BOM:524816) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Natco Pharma 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Natco Pharma's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Natco Pharma (BOM:524816) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (BOM:524816) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

NATCOPHARM:India

Address

Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034

Website

https://www.natcopharma.co.in

Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (BOM:524816) Headlines

No Headlines